Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05748288 · ClinicalTrials.gov registry record
Development of the Virtual Unified Huntington's Disease Rating Scale
A clinical trial, sponsored by Huntington Study Group.
- Completed
- Registry status
- 60
- Enrollment target
NCT05748288 is a clinical trial that has completed, run by Huntington Study Group. The registered enrollment target is 60 participants.
The verdict
NCT05748288 has completed, sponsored by Huntington Study Group.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The Huntington Study Group currently holds the registered trademark for the Unified Huntington's Disease Rating Scale. The UHDRS® is a research tool which has been developed by the HSG to provide a uniform assessment of the clinical features and course of HD. The UHDRS® has undergone extensive reliability and validity testing and has been used as a major outcome measure by the HSG in controlled clinical trials. The purpose of this research study is to determine if a standard HD assessment (the UHDRS®) is as reliable when conducted virtually as it is when conducted at an in-person visit (vUHDRS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-09-22 |
| Est. Completion | 2023-05-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05748288
The ClinicalTrials.gov registry entry for NCT05748288 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Huntington Study Group, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05748288 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05748288 about?
NCT05748288 is a clinical study titled "Development of the Virtual Unified Huntington's Disease Rating Scale". The Huntington Study Group currently holds the registered trademark for the Unified Huntington's Disease Rating Scale. The UHDRS® is a research tool which has been developed by the HSG to provide a uniform assessment of the clinical features and course of HD. The UHDRS® has undergone extensive relia...
What is the current status of trial NCT05748288?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2022-09-22. Estimated completion is 2023-05-02.
Who is sponsoring clinical trial NCT05748288?
This trial is sponsored by Huntington Study Group, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.